{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T20:40:33Z","timestamp":1662064833405},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamaoncol.2021.7784","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T16:00:39Z","timestamp":1644508839000},"page":"641","source":"Crossref","is-referenced-by-count":0,"title":["Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer"],"prefix":"10.1001","volume":"8","author":[{"given":"Binghao","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China"},{"name":"State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China"},{"name":"China Pituitary Disease Registry Center, Chinese Pituitary Adenoma Cooperative Group, Beijing, PR China"},{"name":"China Alliance of Rare Diseases, Beijing, PR China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"9","key":"cle210051r1","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/jamaoncol.2021.2209","article-title":"Nivolumab plus ipilimumab vs nivolumab for previously treated patients with stage IV squamous cell lung cancer: the Lung-MAP S1400I phase 3 randomized clinical trial.","volume":"7","author":"Gettinger","year":"2021","journal-title":"JAMA Oncol"},{"issue":"2","key":"cle210051r2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","article-title":"How the ageing microenvironment influences tumour progression.","volume":"20","author":"Fane","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"cle210051r3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41571-021-00520-1","article-title":"Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.","volume":"18","author":"Grant","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"cle210051r4","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade.","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat Med"},{"issue":"9","key":"cle210051r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamaoncol.2021.2301","article-title":"Pembrolizumab plus concurrent chemoradiation therapy in patients with unresectable, locally advanced, stage III non-small cell lung cancer: the phase 2 KEYNOTE-799 nonrandomized trial.","volume":"7","author":"Jabbour","year":"2021","journal-title":"JAMA Oncol"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2789076\/jamaoncology_zhao_2022_le_210051_1662060008.8323.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T20:00:38Z","timestamp":1662062438000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2789076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.7784","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}